- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
July 3rd, 2010
Arrowhead Research Corp. ended the week down 16 percent to $1 after the Pasadena nanotechnology company closed a $9 million registered direct offering.
Abraxis Bioscience Inc. was the biggest gainer, up nearly 24 percent to $74.25 on news that the L.A. biotech company was being sold to a New Jersey competitor for $2.9 billion.
|Related News Press|
News and information
JEOL Introduces New Best-in-Class Field Emission SEM September 2nd, 2015
TCL and QD Vision Demonstrate the Future of Wide Color Gamut Television at IFA: Color IQ Based Display is the First Commercially-Branded Television to Present Over 90% of ITU Rec. 2020 Color Gamut September 2nd, 2015
Silk bio-ink could help advance tissue engineering with 3-D printers September 2nd, 2015
Phagraphene, a 'relative' of graphene, discovered September 2nd, 2015
Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015